This bill reauthorizes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) for fiscal years 2026–2030 and amends the Public Health Service Act to broaden the program’s purpose, explicitly fund patient navigation and evidence-based strategies to increase screening, and authorize $235,000,000 for FY2026–2030. It also changes program reporting cadence and requires a GAO study on eligibility, service trends, and access barriers.
The changes shift the program from a narrower screening-and-follow-up model toward one that emphasizes prevention, equity, and active facilitation of access (for example, navigation and outreach). That reorientation has practical implications for CDC grant terms, state and tribal grantees’ allowable activities, and how the program measures success and is overseen at the federal level.
At a Glance
What It Does
Reauthorizes NBCCEDP through 2030, inserts language authorizing support activities (patient navigation, evidence-based interventions, facilitation of access), expands the program’s stated mission to include prevention, changes reporting from annual to every five years (with a transitional initial report), and requires a GAO study by Sept. 30, 2027. The bill authorizes $235,000,000 for fiscal year 2026 through 2030.
Who It Affects
CDC and its NBCCEDP grantees—states, the District of Columbia, territories, and Tribal organizations—must adjust program plans and allowable use of funds. Low-income, uninsured, and underinsured women targeted for breast and cervical screening will be the primary beneficiaries; health centers and patient navigation programs will be more directly supported.
Why It Matters
The bill formalizes navigation and equity-focused activities as core program purposes and locks in multi-year funding, which could expand outreach and earlier diagnosis. It also alters reporting and oversight rhythms and creates a focused GAO review intended to inform longer-term program design.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill edits the NBCCEDP’s statutory language to expand what the program is explicitly meant to accomplish. It adds prevention to the program’s stated objectives and elevates support activities — naming patient navigation, implementation of evidence-based or evidence-informed strategies, and facilitation of access to sites that deliver screening — as core means to increase screening rates.
That change signals that the program can fund a wider array of services beyond clinical screening and diagnostic exams.
Several modest but important drafting choices change how responsibility and accountability will play out. The bill replaces the word “monitor” with “ensure” in the statute, which tightens the statutory expectation that programs not only track activities but take steps to make sure follow-up care happens.
It also removes certain subsections in the current statute (striking subsection (d) of two sections) without restating their content, which will require CDC rulemaking or grant guidance to clarify operational expectations formerly set out in those subsections.On reporting and oversight, the bill alters the cadence and the audience: it directs periodic reports to the Senate HELP Committee and the House Energy and Commerce Committee two years after enactment and then every five years thereafter, replacing the prior annual reporting schedule. The text also amends how the baseline reporting period is defined for the first post-enactment report.
Separately, the bill requires the Government Accountability Office to produce an independent study by Sept. 30, 2027, estimating eligible populations, documenting service trends, and assessing barriers to access.Finally, the bill authorizes $235,000,000 for fiscal year 2026 through 2030 for the program. Practically, grantees should expect the ability to use funds for navigation, outreach, and evidence-based interventions while federal and state program managers will need to translate statutory language into grant conditions, performance measures, and data-collection requirements that capture both screening and the supportive services now emphasized in statute.
The Five Things You Need to Know
The bill amends Section 1501(a) of the Public Health Service Act to add prevention, patient navigation, evidence‑based strategies, and facilitation of access to the program’s core purposes.
It changes statutory wording from “monitor” to “ensure” regarding follow-up services, tightening the program’s duty to secure post‑screening care.
Reporting in Section 1508(b) shifts from annual reports to one report two years after enactment and then every five years, and directs reports to the Senate HELP and House Energy & Commerce Committees.
Section 1510(a) authorizes $235,000,000 for fiscal year 2026 through 2030 to support NBCCEDP activities.
The bill requires the GAO to report by Sept. 30, 2027 on eligible populations, trends in individuals served, and barriers to accessing NBCCEDP screening services.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Expands the program’s stated purposes to include prevention and navigation
This amendment inserts prevention explicitly into the NBCCEDP’s purposes and adds support activities such as navigation of health care services, evidence‑based strategies to increase screening, and facilitation of access to screening sites. Practically, that broadens the scope of grant‑funded activities beyond clinical screening and diagnostic exams to include outreach, coordination, and systems work designed to bring people into care.
From 'monitor' to 'ensure' — stronger statutory expectation for follow-up
Replacing “monitor” with “ensure” raises statutory expectations that grantees take active steps to secure appropriate follow‑up care after abnormal screening results. That change will require CDC and grantees to define what it means to ensure care (e.g., referral pathways, guaranteed appointment slots, or financial assistance for diagnostics) rather than merely track whether follow‑up occurred.
Aligns screening and diagnostic service standards with evidence-based recommendations
The bill narrows and clarifies Section 1503(a) so that grants must support breast and cervical screening and diagnostic services consistent with relevant evidence‑based recommendations. Removing other paragraphs from subsection (a) and striking subsection (d) will force administrative guidance to fill any operational gaps left by the deleted text; grantees should expect updated program manuals and performance metrics tied to current clinical guidelines.
Alters reporting frequency and committee recipients
This amendment changes the program’s reporting timetable to the Congress: the first required report is due two years after enactment and subsequent reports every five years, rather than annually. It also changes the named Senate committee to Health, Education, Labor, and Pensions (HELP) and adjusts the look‑back windows used in the reports. Those changes will reduce the frequency of statutory reporting but increase the length of time each report must synthesize.
Authorizes funding and mandates a GAO study
The bill inserts an authorization of $235,000,000 for fiscal year 2026 through 2030 into Section 1510(a). Separately, a new statutory section requires the Government Accountability Office to deliver a report by Sept. 30, 2027 estimating program eligibility, summarizing service trends, and assessing barriers to access. Together, these provisions pair a near‑term funding commitment with an independent review intended to inform future program design and resourcing.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Low‑income, uninsured, and underinsured women who rely on NBCCEDP — they gain explicit statutory support for navigation and access activities intended to increase screening uptake and speed diagnosis.
- State health departments, territories, and Tribal organizations — expanded allowable activities and a multi‑year authorization give program managers clearer authority to fund outreach, patient navigation, and evidence‑based interventions.
- Community health centers and patient navigation programs — the statutory recognition of navigation and facilitation of access makes them more likely recipients of grant funding and partnership opportunities.
- Public health grants managers and program evaluators — the GAO study and revised reporting windows create opportunities to reshape performance metrics and program evaluation frameworks with federal input.
Who Bears the Cost
- Federal appropriations (Congress and HHS) — the authorization of $235,000,000 for FY2026–2030 represents a new budgetary commitment that Congress must fund to realize the program’s expanded activities.
- CDC and grant administrators — agencies must translate broader statutory language into grant terms, guidance, and monitoring systems, incurring administrative and analytic work.
- State, tribal, and territorial grantees — programs will need to retool operations to deliver navigation, evidence‑based interventions, and expanded outreach, which can create short‑term administrative and staffing costs.
- Clinical providers and screening sites — increased outreach and facilitated access may raise demand for screening and diagnostic services, requiring capacity adjustments or new coordination arrangements.
Key Issues
The Core Tension
The bill balances an expanded statutory ambition — moving from monitoring screenings to ensuring follow‑up and actively facilitating access through navigation and evidence‑based interventions — against a fixed, singular authorization figure and less frequent statutory reporting; the central dilemma is achieving broader, more proactive services without commensurate, guaranteed funding or near‑term oversight to adjust course rapidly.
The bill strengthens program language and expands permissible activities, but it leaves several implementation questions unresolved. Striking subsection (d) from two statutory sections removes existing statutory text without replacing its substance in-line, which transfers important definitional and operational work to agency guidance.
That invites variation in how CDC translates “ensure” and “facilitation of access” into enforceable grant conditions and performance indicators.
The authorized funding level is explicit but limited: authorizing $235 million for the multi‑year period establishes a floor for congressional appropriation discussions but does not guarantee that level will be appropriated. If Congress underfunds the authorization, grantees will face pressure to prioritize among clinical screenings, navigation, outreach, and other activities now within statute.
Finally, changing reporting to a multi‑year cadence improves the potential depth of each report but reduces the frequency of statutory oversight, which could slow detection of emerging access problems or program shortfalls between mandated reports.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.